CoChat

Point-of-Care Urine Lipoarabinomannan Testing to Guide Tuberculosis Treatment Among Severely Ill Inpatients With Human Immunodeficiency Virus in Real-World Practice: A Multicenter Stepped Wedge Cluster-Randomized Trial From Ghana

Open access

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The lateral flow urine lipoarabinomannan assay, Determine TB LAM (Determine LAM), offers the potential for timely tuberculosis (TB) treatment among people with human immunodeficiency virus (PWH). METHODS: In this cluster-randomized trial, Determine LAM was made available with staff training with performance feedback at 3 hospitals in Ghana. Newly admitted PWH with a positive World Health Organization four-symptom screening for TB, severe illness, or advanced HIV were enrolled. The primary outcome was days from enrollment to TB treatment initiation. We also reported the proportion of patients with a TB diagnosis, initiating TB treatment, all-cause mortality, and Determine LAM uptake at 8 weeks. RESULTS: We enrolled 422 patients including 174 (41.2%) in the intervention group. The median CD4 count was 87 (interquartile range [IQR], 25-205) cells/μL, and 32.7% were on antiretroviral therapy. More patients were diagnosed with TB in the intervention compared with the control group: 59 (34.1%) versus 46 (18.7%) (P < .001). Time to TB treatment remained constant, but patients were more likely to initiate TB treatment (adjusted hazard ratio, 2.19 [95% CI, 1.60-3.00]) during the intervention. Of patients with a Determine LAM test available, 41 (25.3%) tested positive. Of those, 19 (46.3%) initiated TB treatment. Overall, 118 patients had died (28.2%) at 8 weeks of follow-up. CONCLUSIONS: The Determine LAM intervention in real-world practice increased TB diagnosis and the probability of TB treatment but did not reduce time to treatment initiation. Despite high uptake, only half of the LAM-positive patients initiated TB treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciad316

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

3 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 3

  1. World Health Organization (WHO), 2015, The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Policy update
  2. Bonsu, 2018, Standard operating procedures for systematic screening for active TB at health facility and different settings
  3. World Health Organization (WHO), 2017, Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

Cited by

See all 16

Metadata

Authors
Åhsberg, J., Puplampu, P., Kwashie, A., Commey, J. O., Ganu, V. J., Omari, M. A., Adusi-Poku, Y., Andersen, Å. B., Kenu, E., Lartey, M., Johansen, I. S., & Bjerrum, S.
Affiliations
  • Statens Serum Institut (DK)
  • University of Ghana (GH)
  • Department of Medicine, Tema General Hospital , Tema, Ghana
  • Ghana Health Service (GH)
  • Korle Bu Teaching Hospital (GH)
  • Copenhagen University Hospital (DK)
  • Research Center of Infectious Diseases, Department of Clinical Research, University of Southern Denmark , Odense, Denmark
  • University of Southern Denmark (DK)
Corresponding author
  • Åhsberg, Johanna
  • Bjerrum, Stephanie
Venue
Clinical Infectious Diseases
Published
2023-05-26
Volume
77
Issue
8
Pages
1185-1193
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W4378349612
Cited by
14
References
29
Citations by year
2026: 3 · 2025: 9 · 2024: 2
FWCI
2.90
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Funders
  • Læge Agnethe Løvgreens legat
  • Torben og Alice Frimodts fond
  • A.P. Møller fonden
  • University of Southern Denmark
  • Odense University Hospital
  • Strategic Research Council
Topics
  • Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
  • Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
tuberculosis, HIV, lipoarabinomannan, point-of-care testing, TB treatment initiation, tuberculosis diagnosis, severe illness, hospitalized patients, all-cause mortality, employee training, performance feedback, Ghana
MeSH terms
Point-of-Care Testing, Adult, Antitubercular Agents, Female, Ghana, Humans, Inpatients, Lipopolysaccharides, Male, Middle Aged, Tuberculosis, HIV Infections

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.